Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Cablevisión Holding reports 30.5% revenue growth and 36.9% EBITDA rise in Q1 2026, boosted by Telefónica Móvil acquisition.

Company Fundamentals
11 May 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Cablevisión Holding S.A. announced a 30.5% increase in total revenues to Ps. 2,357,686 million and a 36.9% rise in EBITDA to Ps. 814,217 million for Q1 2026, driven mainly by the acquisition of Telefónica Móvil Argentina (TMA) in February 2025 and higher mobile service prices. Despite higher costs due to TMA integration, the company improved cost efficiencies, raising its EBITDA margin to 34.5%. Consolidated net income attributable to shareholders surged to Ps. 234,688 million. The results highlight CVH's strengthened market position and financial performance following the acquisition, with a webcast scheduled to discuss details further.

More News

Liminatus Pharma to be delisted from Nasdaq for failing market value rules, plans to appeal.

Liminatus Pharma to be delisted from Nasdaq for failing market value rules, plans to appeal.

Liminatus Pharma received a delisting notice from Nasdaq due to failure to meet minimum market value requirements for its listed securities and publicly held shares. The company was given until May 18, 2026, to regain compliance but did not meet the ...

Market News
Bearish
1 hour ago
Audiencerate appoints Riccardo Fabbri as CTO to lead AI-driven platform expansion for SMEs and media agencies.

Audiencerate appoints Riccardo Fabbri as CTO to lead AI-driven platform expansion for SMEs and media agencies.

Audiencerate Ltd has named Riccardo Fabbri as its new Chief Technology Officer, marking the start of an AI-driven expansion phase for its platforms serving Italian SMEs and global media agencies. Fabbri, with over 20 years of experience in software a...

Company Fundamentals
Bullish
2 hours ago
Biogen and Denali halt BIIB122 development after Phase 2b Parkinson's study fails to meet endpoints

Biogen and Denali halt BIIB122 development after Phase 2b Parkinson's study fails to meet endpoints

Biogen and Denali announced that their Phase 2b LUMA study of BIIB122 (DNL151) in early-stage Parkinson's disease did not meet its primary or secondary endpoints, showing no slowing of disease progression compared to placebo. Despite good safety and ...

Company Fundamentals
Bearish
3 hours ago
Samba TV launches Project Gravity, a platform for real-time data activation across major ad platforms.

Samba TV launches Project Gravity, a platform for real-time data activation across major ad platforms.

Samba TV has introduced Project Gravity, an independent data onboarding and activation platform that integrates advertisers' first-party data with over 40 leading advertising platforms like Google DV360, Meta, and TikTok. Designed for the agentic era...

Others
Bullish
3 hours ago
Biogen and Denali halt BIIB122 development after Phase 2b study fails to slow early Parkinson's progression

Biogen and Denali halt BIIB122 development after Phase 2b study fails to slow early Parkinson's progression

Biogen and Denali announced that their Phase 2b LUMA study of BIIB122, a drug targeting early-stage Parkinson's disease, did not meet its primary or secondary endpoints, showing no slowing of disease progression compared to placebo. Despite good safe...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App